FTSE 250 movers: Oxford Biomedica tumbles on tariff sentiment

FTSE 250 (MCX) 21,688.17 0.47%

26 September 2025 16:01:56

Source: Sharecast

Oxford Biomedica shares slumped after US President Donald Trump announced a new raft of tariffs, including 100% on branded drugs.

Trump said the US would impose 100% levies on imported branded drugs, 25% on heavy-duty trucks and 50% on kitchen cabinets.

Bathroom vanities would be slapped with a 50% tariff while upholstered furniture would face duties of 30%.

All the new charges would take effect on October 1, Trump added via social media posts with exemptions for those companies that built factories in America.

Dr Martens led the risers, although there was no apparent reason for the jump.

FTSE 250 - Risers

Dr. Martens (DOCS) 94.65p 3.44%
Johnson Service Group (JSG) 148.00p 3.21%
Kier Group (KIE) 214.50p 3.13%
Greggs (GRG) 1,556.00p 2.77%
PayPoint (PAY) 668.00p 2.30%
International Workplace Group (IWG) 215.00p 2.28%
Grainger (GRI) 186.00p 2.09%
THG (THG) 36.12p 2.03%
Chemring Group (CHG) 564.00p 1.81%
Raspberry PI Holdings (RPI) 419.30p 1.77%

FTSE 250 - Fallers

Oxford Biomedica (OXB) 537.00p -6.28%
Ashoka India Equity Investment Trust (AIE) 259.50p -1.89%
Pinewood Technologies Group (PINE) 426.50p -1.84%
Victrex plc (VCT) 683.00p -1.73%
Future (FUTR) 651.50p -1.66%
Tate & Lyle (TATE) 451.60p -1.27%
Hochschild Mining (HOC) 337.20p -1.06%
JPMorgan Indian Investment Trust (JII) 1,014.00p -0.98%
Templeton Emerging Markets Inv Trust (TEM) 216.00p -0.92%
Pantheon Infrastructure (PINT) 108.00p -0.92%

Transferring your account

Transfer your existing ISAs and Share Dealing Accounts and you could save money. In order to transfer, log in to your existing account and complete the online application form. We’ll do the rest for you. It’s free to transfer (we will not charge you). Please check your current provider to see if they have any charges for transferring.

Transfer to us

Compare our accounts

If you're looking to grow your money over the longer term (5+ years), we have a range of investment choices to help.

View our accounts

IWeb is not responsible for the content and accuracy of the Markets News articles. We may not share the views of the author. Understand the risks, please remember the value of your investment can go down as well as up and you may not get back the full amount you invest. We don't provide advice so if you are in any doubt about buying and selling shares or making your own investment decisions we recommend you seek advice from a suitably qualified Financial Advisor. Past performance is not a guide to future performance.

Important legal information

The IWeb Share Dealing Service is operated by Halifax Share Dealing Limited. Halifax Share Dealing Limited. Registered in England and Wales no. 3195646. Registered Office: Trinity Road, Halifax, West Yorkshire, HX1 2RG. Authorised and regulated by the Financial Conduct Authority, 12 Endeavour Square, London, E20 1JN under registration number 183332. A Member of the London Stock Exchange and an HM Revenue & Customs Approved ISA Manager.

The information contained within this website is provided by Allfunds Digital, S.L.U. acting through its business division Digital Look Ltd unless otherwise stated. The information is not intended to be advice or a recommendation to buy, sell or hold any of the shares, companies or investment vehicles mentioned, nor is it information meant to be a research recommendation. This is a solution powered by Allfunds Digital, S.L.U. acting through its business division Digital Look Ltd incorporating their prices, data news, charts, fundamentals and investor tools on this site. Terms and conditions apply. Prices and trades are provided by Allfunds Digital, S.L.U. acting through its business division Digital Look Ltd and are delayed by at least 15 minutes.

The data provided on the website by Broadridge is not intended to be advice or a recommendation to buy, sell or hold any of the shares, companies or investment vehicles mentioned, nor is it information meant to be a research recommendation. Broadridge makes no assurances or warranties, expressed or implied, as to the accuracy, timeliness, fitness for purpose or availability of the mechanisms by which we receive, store and/or distribute the data. Any views and opinions made on this website do not represent those of Broadridge.